Antony, France

Jean-Christophe Delumeau

This inventor holds 1 USPTO granted patent. Top assignee: Rhone-Poulenc Rorer S.a.. Active years: 1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jean-Christophe Delumeau. Retrieved from https://idiyas.com/inventor/jean-christophe-delumeau

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Jean-Christophe Delumeau

Introduction

Jean-Christophe Delumeau is a notable inventor based in Antony, France. He has made significant contributions to the field of medicine, particularly in the treatment of mitochondrial diseases. His work has led to the development of innovative solutions that address critical health issues.

Latest Patents

Jean-Christophe Delumeau holds a patent for the "Application of riluzole in the treatment of mitochondrial diseases." This patent represents a significant advancement in therapeutic options for patients suffering from these complex conditions. He has 1 patent to his name, showcasing his commitment to innovation in healthcare.

Career Highlights

Delumeau is associated with Rhône-Poulenc Rorer S.A., a company known for its dedication to pharmaceutical advancements. His role in this organization has allowed him to collaborate with other talented professionals in the field, further enhancing his contributions to medical science.

Collaborations

Throughout his career, Jean-Christophe Delumeau has worked alongside esteemed colleagues such as Michel Martinet and Michel Reibaud. These collaborations have fostered an environment of innovation and creativity, leading to impactful developments in their respective fields.

Conclusion

Jean-Christophe Delumeau's work exemplifies the spirit of innovation in the medical field. His contributions, particularly in the treatment of mitochondrial diseases, highlight the importance of research and collaboration in advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…